A Case Study of Pain Management at End-of-Life for a Patient on High-Dose Buprenorphine
In Australia, high-dose sublingual buprenorphine and long-acting injectable buprenorphine are available. High-dose buprenorphine is used predominantly in the setting of opioid use disorder and has a role in chronic pain. Palliative care specialists are increasingly involved in pain management and en...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2022-02-01
|
| Series: | Journal of Patient Experience |
| Online Access: | https://doi.org/10.1177/23743735221079141 |